Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Eun Hyoung Jeong, M.D., Dong Hyun Kim, M.D., Sung Ho Ma, M.D., Eui Jong Chung, M.D., Sang Su Bae, M.D., A Young Park, M.D. Hyung Jun Chu, M.D.

Clin Mol Hepatol. 2009;15(2):201-208. Published online June 30, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.2.201

View: 4687 Download: 49 Crossref: 2

Young Tae Hwang, M.D. Jung Woo Shin, M.D. Jun Ho Lee, M.D. Dae Sung Hwang, M.D. Jun Bum Eum, M.D. Hye Jeong Choi, M.D. Neung Hwa Park, M.D.

Clin Mol Hepatol. 2007;13(4):565-570. Published online December 20, 2007

DOI: https://doi.org/10.3350/kjhep.2007.13.4.565

View: 4463 Download: 36 Crossref: 2

Min An, M.D., Jeong A Shin, M.D., Sang-Min Lee, M.D., Tak Yoon, M.D. Weon Seo Park, M.D. Joon Il Choi, M.D., and Chang-Min Kim, M.D.

Clin Mol Hepatol. 2006;12(4):562-567. Published online January 1, 1970

View: 2753 Download: 29

Joon Koo Han,Se Hyung Kim

Clin Mol Hepatol. 2002;8(2):228-230. Published online January 1, 1970

View: 2200 Download: 23

1 |

Viewed By 5633	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 4854	MAFLD: How is it different from NAFLD?
Viewed By 4609	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3750	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3739	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 135	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 80	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 68	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 57	MAFLD: How is it different from NAFLD?

Search